Pfizer
Amoy Diagnostics, Pierre Fabre Collaborate to Develop CDx in China
The companion diagnostic kits will support marketing authorization applications for Pfizer's Braftovi and Mektovi.
The project involves numerous biopharmaceutical firms, including Pfizer, Roche, Takeda Pharmaceuticals, Sanofi, Novartis, ProQR Therapeutics, Lysogene, and Novo Nordisk.
The short oligo ligation assembly (SOLA) enzymatic DNA synthesis method uses a library of DNA building blocks to make oligos that are then assembled into genes.
The purchase of GeneDx from Opko Health will help Sema4 accelerate its push into whole-exome sequencing and grow in rare disease diagnostics.
Sema4 to Acquire GeneDx for $623M
While GeneDx parent Opko Health is essentially exiting the MDx business, it will pick up a "significant" stake in Sema4.
Jul 28, 2021
Oct 30, 2020
Opko Health Q3 Revenues Up 87 Percent
Jun 4, 2019
Apr 30, 2019
Exact Sciences Q1 Revenues Up 79 Percent
Oct 30, 2018
Exact Sciences Q3 Revenues Up 63 Percent
Oct 30, 2018
Precision Oncology Highlights From ESMO 2018
Oct 12, 2018
AmoyDx Lung Cancer CDx Approved in South Korea
Aug 22, 2018